Last reviewed · How we verify
NCT06994689: Metriquad
Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD
trial testing Perimetry and ShearWave measurement of the quadriceps muscle before and after a pulmonary rehabilitation (PR) programme in COPD in 30 participants. Currently enrolling.
1 October 2026
Quick facts
| Lead sponsor | Groupe Hospitalier du Havre |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 30 May 2025 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Perimetry and ShearWave measurement of the quadriceps muscle before and after a pulmonary rehabilitation (PR) programme
Conditions studied
- COPD — all drugs for COPD →
- Quadriceps Muscle Atrophy — all drugs for Quadriceps Muscle Atrophy →
Sponsor
Groupe Hospitalier du Havre
Who can join
18 and older, any sex, with COPD or Quadriceps Muscle Atrophy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association between a loss of quadriceps muscle mass and premature death. This study aims to investigate the clinimetric properties of a simple quadriceps perimetry and ShearWave elastography to improve the monitoring of skeletal muscle function in patients with COPD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06994689
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COPD
Currently open trials in the same condition.
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
Other Groupe Hospitalier du Havre trials
Trials by the same sponsor.
- NCT07371754 — Shear Wave Elastography of Intercostal Muscles for the Non-invasive Assessment of the Work of BreathinG · not yet recruiting
- NCT07492745 — Effect of Using a Reminder to Encourage Patients to be Active During Their Hospital Stay. · NA · recruiting
- NCT06249412 — The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients · NA · recruiting
- NCT06772701 — Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father · NA · recruiting
- NCT05654597 — French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06994689 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Groupe Hospitalier du Havre
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06994689.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing